1 Min Read
Sept 27 (Reuters) - Therapix Biosciences Ltd
* Therapix’s first-in-class therapy demonstrates reversal of age-related cognitive impairment in pre-clinical study Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.